| Patents for C07K 1 - General processes for the preparation of peptides (51,718) |
|---|
| 01/23/2002 | EP0815122B1 Process for preparation of pure cyclosporin chromatographically using an eluent consisting essentially of high pressure carbon dioxide |
| 01/23/2002 | EP0796269B1 Filtration method for removing viruses from virus-contaminated aqueous solutions |
| 01/23/2002 | EP0787137B1 Process for the preparation of n-carboxyanhydride amino acids from n-(n'-nitrosocarbamoyl)amino acids |
| 01/23/2002 | CN1078250C Reshaped monoclonal antibodies against immunoglobulin isotype |
| 01/23/2002 | CN1078204C Amino acid amide derivative and fungicidal use and production process thereof |
| 01/22/2002 | US6341256 Consensus configurational bias Monte Carlo method and system for pharmacophore structure determination |
| 01/22/2002 | US6340588 A library of molecules or biological particles that are linked to and synthesized on a solid support comprising of a matrix treated for linking the molecules and particles and the surface is imprinted or engraved with optically encoded data |
| 01/22/2002 | CA2038398C Dna encoding a growth factor specific for epithelial cells |
| 01/22/2002 | CA1341333C Amylin peptides and uses thereof |
| 01/17/2002 | WO2002005146A2 Method for disigning protein libraries with altered immunogenicity |
| 01/17/2002 | WO2002004520A2 Transporters and ion channels |
| 01/17/2002 | WO2002004515A1 Insulin derivatives and synthesis thereof |
| 01/17/2002 | WO2002004490A2 Lipid metabolism molecules |
| 01/17/2002 | WO2002004483A1 Biologically active protein conjugates formed by first protecting active site |
| 01/17/2002 | WO2002004481A2 Process to increase protein stability |
| 01/17/2002 | WO2001049741A3 A process for isolation of osteopontin from milk |
| 01/17/2002 | WO2001046216A3 Use of an anion exchange resin (epm-7) as solid support for peptide synthesis and affinity chromatography |
| 01/17/2002 | WO2001040312A3 Naive screening method |
| 01/17/2002 | US20020007052 Point mutations; genetic engineering; hybridization |
| 01/17/2002 | US20020007048 Solution Phase Biopolymer Synthesis |
| 01/17/2002 | US20020006672 Generating preferential matrix; embedded particles in matrix, form transfer aggregations, heat, dissolve transfer aggregations, apply to matrix, vaporize, link transfer aggregation in matrix, allow gelation repeat in another |
| 01/17/2002 | US20020006671 Luminescence polarization assays |
| 01/17/2002 | US20020006652 Nucleic acids encoding polypeptides having haloperoxidase activity |
| 01/17/2002 | US20020006648 Free-form fabrication using multi-photon excitation |
| 01/17/2002 | US20020006636 Chaperonin and osmolyte protein folding and related screening methods |
| 01/17/2002 | US20020006604 Solid support for the detection of preferential compounds in sample |
| 01/17/2002 | CA2415902A1 Protein design automation for designing protein libraries with altered immunogenicity |
| 01/17/2002 | CA2415808A1 Transporters and ion channels |
| 01/17/2002 | CA2415425A1 Insulin derivatives and synthesis thereof |
| 01/17/2002 | CA2415158A1 Biologically active protein conjugates formed by first protecting activesite |
| 01/17/2002 | CA2414219A1 Lipid metabolism molecules |
| 01/16/2002 | EP1172373A2 Method for preparing zinc-oligopeptide easily absorbable by the human body |
| 01/16/2002 | EP1171489A1 Amino group containing support matrices, their use and manufacture |
| 01/16/2002 | EP1171468A2 Method for the stabilization of chimeric immunoglobulins or immunoglobulin fragments, and stabilized anti-egp-2 scfv fragment |
| 01/16/2002 | EP1171464A2 Peptide homodimers or peptide heterodimers derived from interleukin 12 |
| 01/16/2002 | EP1171463A2 Peptide homodimers and peptide heterodimers, derived from interferon alpha 2 |
| 01/16/2002 | EP1171455A1 Polypeptide-k obtained from momordica charantia and a process for the extraction thereof |
| 01/16/2002 | EP1171405A1 Functionalised solid support for alpha-oxoaldehyde synthesis |
| 01/16/2002 | EP1019095B1 Method for the preparation of facial metal tricarbonyl compounds and their use in the labelling of biologically active substrates |
| 01/16/2002 | EP0794960B1 An aglucone isoflavone enriched vegetable protein concentrate and process for producing |
| 01/16/2002 | CN1331699A Methods of identifying antigen gene sequences |
| 01/16/2002 | CN1331083A Memory-improving peptides and their application |
| 01/15/2002 | US6339142 Protein purification |
| 01/15/2002 | US6339069 Administering formulation comprising pharmaceutically acceptable carrier; and, liposome comprising a bioactive agent and a lipid component, the lipid component comprising a peptide-lipid conjugate |
| 01/15/2002 | US6339061 Process for the stabilization of proteins in complex mixtures during their storage in aqueous solvents |
| 01/15/2002 | US6338849 Process of preparing immunoglobulin for intravenous injection by viruses double-sterilized without adding any protectant |
| 01/15/2002 | CA2022444C Lhrh analogs |
| 01/15/2002 | CA2001719C Phosphorylated fusion proteins and uses related thereto |
| 01/10/2002 | WO2002002772A2 Human extracellular matrix (ecm)-related tumor marker |
| 01/10/2002 | WO2002002634A2 Human extracellular matrix and cell adhesion polypeptides |
| 01/10/2002 | WO2002002633A2 Transporters and ion channels |
| 01/10/2002 | WO2002002610A2 Secretion and trafficking molecules |
| 01/10/2002 | WO2002002607A2 Acid-modified arabinogalactan protein composition |
| 01/10/2002 | WO2002002596A2 Synthetic methods for aplidine and new antitumoral derivatives, methods of making and using them |
| 01/10/2002 | WO2002002592A1 Memory-enhancing peptides and the use thereof |
| 01/10/2002 | WO2002002591A2 Peptides for use in culture media |
| 01/10/2002 | WO2002002488A2 Methods and compounds for modulating nuclear receptor coactivator binding |
| 01/10/2002 | WO2002002150A2 Stable radioiodine conjugates and methods for their synthesis |
| 01/10/2002 | WO2002002132A1 Chemokine conjugates |
| 01/10/2002 | WO2001030804A3 Salt form of a conjugate useful in the treatment of prostate cancer |
| 01/10/2002 | WO2001028593A3 Conjugates useful in the treatment of prostate cancer |
| 01/10/2002 | US20020004706 Apparatus and method for automated protein design |
| 01/10/2002 | US20020004586 Prion-binding activity in serum and proteins |
| 01/10/2002 | US20020004215 Adjusting preferental particles to generate signal; mix ligand and marker, enzyme, incubate, allow binding, detect signal |
| 01/10/2002 | US20020004211 Methods for isolating and characterizing endogenous mRNA-protein (mRNP) complexes |
| 01/10/2002 | CA2415103A1 Methods and compounds for modulating nuclear receptor coactivator binding |
| 01/10/2002 | CA2413186A1 Extracellular matrix and cell adhesion molecules |
| 01/10/2002 | CA2413166A1 Acid-modified arabinogalactan protein composition |
| 01/10/2002 | CA2413158A1 Ecm-related tumor marker |
| 01/10/2002 | CA2413128A1 Transporters and ion channels |
| 01/10/2002 | CA2410679A1 Secretion and trafficking molecules |
| 01/09/2002 | EP1170301A1 Process of preparation of peptides and N-carbamoyl protected peptides |
| 01/09/2002 | EP1170300A1 Method for modification of recombinant polypeptides |
| 01/09/2002 | EP1169648A1 Use of 13c-nmr to detect binding |
| 01/09/2002 | EP1169470A1 Methods and reagents for determining enzyme substrate specificity, and uses related thereto |
| 01/09/2002 | EP1169456A1 Recombinant toxin a/toxin b vaccine against clostridium difficile |
| 01/09/2002 | EP1169349A2 Highly purified gonadotropin compositions and process for preparing them |
| 01/09/2002 | EP1169282A1 Site-specific isotopically-labeled proteins, amino acids, and biochemical precursors therefor |
| 01/09/2002 | EP1169048A2 Hyaluronic acid mimics and methods related thereto |
| 01/09/2002 | EP0693052B1 Deallylation reagent and deallylation method using said reagent |
| 01/09/2002 | CN1330675A Polyamide chains of precise length, methods to manufacture them and their conjugates with protein |
| 01/09/2002 | CN1330661A Procollagen C-proteinase inhibitors |
| 01/09/2002 | CN1077438C Recombinant coccidiosis vaccines |
| 01/08/2002 | US6337393 Reducing liquid evaporation during solid phase micro-scale synthesis on an open environment solid support surface; the liquid reagent is a solvent with a high boiling point to prevent evaporation while maintaining a high reaction yield |
| 01/08/2002 | US6337319 μ-Selective opioid peptides |
| 01/08/2002 | US6337179 Methods and kits for detecting antibodies against an HIV variant |
| 01/08/2002 | CA2057493C A process for the preparation of a pasteurized and iron-free human transferrin |
| 01/08/2002 | CA2021594C Antibody to human interleukin-6 receptor |
| 01/08/2002 | CA2019559C Bispecific and oligospecific mono- and oligovalent receptors, the preparation and use thereof |
| 01/03/2002 | WO2002000684A2 Method of obtaining peptides with tissue-specific activity and pharmaceutical compositions on their basis |
| 01/03/2002 | WO2001073125A3 High throughput screening array containing porous material |
| 01/03/2002 | WO2001071732A3 Porous ferro- or ferrimagnetic glass particles for isolating molecules |
| 01/03/2002 | WO2001070275A3 Polyglutamic acid-camptothecin conjugates and methods of preparation |
| 01/03/2002 | WO2001016862A3 Methods and compositions utilizing a branch and terminate algorithm for protein design |
| 01/03/2002 | US20020002271 Separating immunoglobulin from mixture; load sample onto chromatographic apparatus, elute immunoglobulin |
| 01/03/2002 | US20020002270 Purified antigen for alzheimer's disease, and methods of obtaining and using same |
| 01/03/2002 | US20020002165 Growth hormone secretagogues useful for treatment/prevention of osteoporosis |
| 01/03/2002 | US20020001591 Compositions for the delivery of antigens |
| 01/03/2002 | DE10029139A1 Verfahren zur Herstellung von Amiden oder Estern A process for producing amides or esters |
| 01/02/2002 | EP1167522A1 Method for screening biomolecule activity regulator |